We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

197 hedge funds and large institutions have $911M invested in SANGAMO THERAPEUTICS INC in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 74 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $16.9M | Put options by funds: $11M

2.49% less ownership

Funds ownership: 55.46% → 52.97% (-2.5%)

3% less funds holding

Funds holding: 203 → 197 (-6)

8% less capital invested

Capital invested by funds: $994M → $911M (-$82.9M)

20% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 74

22% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 23

Holders
197
Holders Change
-6
Holders Change %
-2.96%
% of All Funds
3.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
59
Reduced
74
Closed
23
Calls
$16.9M
Puts
$11M
Net Calls
+$5.86M
Net Calls Change
-$799K

Top Buyers

Rank Fund Capital Flow
1
SG Americas Securities
SG Americas Securities
New York
+$5.95M
2
JP Morgan Chase
JP Morgan Chase
New York
+$4.79M
3
LOAMS
Lombard Odier Asset Management (Switzerland)
Switzerland
+$4.06M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.98M
5
Morgan Stanley
Morgan Stanley
New York
+$2M

Top Sellers

Rank Fund Capital Flow
1
CLOS
Compagnie Lombard Odier SCmA
Switzerland
-$9.61M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.52M
3
State Street
State Street
Massachusetts
-$6.21M
4
BBA
Baker Bros. Advisors
New York
-$5.38M
5
Citadel Advisors
Citadel Advisors
Florida
-$5.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$6.98M -$2.23M -196,600 -25%
CC
27
Casdin Capital
New York
$6.58M – – –
Two Sigma Investments
28
Two Sigma Investments
New York
$6.43M -$4.31M -380,884 -42%
Hudson Bay Capital Management
29
Hudson Bay Capital Management
Connecticut
$5.39M +$1.3M +115,000 +34%
Citigroup
30
Citigroup
New York
$5.37M +$134K +11,878 +3%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$4.85M -$963K -85,063 -17%
Macquarie Group
32
Macquarie Group
Australia
$4.81M -$11.1K -976 -0.2%
Fidelity Investments
33
Fidelity Investments
Massachusetts
$4.32M -$1.61M -142,399 -28%
Bank of America
34
Bank of America
North Carolina
$4.29M +$25.2K +2,223 +0.6%
Mirae Asset Global Investments
35
Mirae Asset Global Investments
South Korea
$3.63M +$454K +40,100 +15%
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$3.38M +$176K +15,552 +6%
B
37
Bailard
California
$3.34M -$493K -43,500 -13%
Swiss National Bank
38
Swiss National Bank
Switzerland
$3.21M -$71.3K -6,300 -2%
RJFSA
39
Raymond James Financial Services Advisors
Florida
$3.02M +$105K +9,267 +4%
PP
40
PDT Partners
New York
$2.97M +$203K +17,894 +8%
MIG
41
McGuire Investment Group
Rhode Island
$2.94M -$307K -27,083 -10%
GIM
42
Granahan Investment Management
Massachusetts
$2.77M +$146K +12,876 +6%
State of New Jersey Common Pension Fund D
43
State of New Jersey Common Pension Fund D
New Jersey
$2.75M +$664K +58,627 +34%
PIM
44
Platinum Investment Management
Australia
$2.61M – – –
AGA
45
Altrinsic Global Advisors
Connecticut
$2.59M – – –
Rafferty Asset Management
46
Rafferty Asset Management
New York
$2.5M -$902K -79,667 -28%
OC
47
Oppenheimer & Co
New York
$2.36M +$1.48M +130,300 +196%
AA
48
ALPS Advisors
Colorado
$2.27M -$752K -66,376 -26%
Connor, Clark & Lunn Investment Management (CC&L)
49
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.21M +$1.07M +94,506 +105%
Ohio Public Employees Retirement System (OPERS)
50
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.12M – – –
1
2
3 4 5

SGMO Hedge Fund Activity: Q2 2021 in Review

197 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2021, worth a combined $911M — down 8.3% from $994M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of SGMO and 18 opened new positions — a net loss of 5 holders — while 74 trimmed existing stakes and 59 added.

The largest buyer was SG Americas Securities, adding an estimated $5.95M. The largest seller was Compagnie Lombard Odier SCmA, cutting an estimated $9.61M.

  • 197 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2021, down from 203 in Q1 2021.
  • Funds reported $911M of SANGAMO THERAPEUTICS INC stock for Q2 2021, down 8.3% quarter-over-quarter.
  • 18 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2021 and 23 closed out, a net change of -5 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2021 was SG Americas Securities, an estimated $5.95M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2021 was Compagnie Lombard Odier SCmA, an estimated $9.61M sold.

Based on aggregated 13F filings for Q2 2021.